Position in GILD
as of Jun 30, 2026
· filed Aug 12, 2026
Position Value
$27,415
+$796 QoQ
Shares Held
217
+13.6% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
#2,112
of 2,266 holders
Holding Since
Mar 2025
6 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in GILD Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026S&T Bank/PA holds $6,307,683 across 11 Drug Manufacturers - General names. GILD ranks #9 (0.4% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ABBV |
AbbVie Inc.
|
18,356 | $4,619,103 | |
| 2 | JNJ |
Johnson & Johnson
|
2,265 | $575,242 | |
| 3 | LLY |
ELI LILLY & Co
|
302 | $362,227 | |
| 4 | MRK |
Merck & Co., Inc.
|
1,829 | $235,026 | |
| 5 | AMGN |
Amgen Inc
|
396 | $143,399 | |
| 6 | BMY |
Bristol Myers Squibb Co
|
2,458 | $141,629 | |
| 7 | PFE |
Pfizer Inc
|
5,442 | $131,042 | |
| 8 | NVO |
Novo Nordisk A S
|
1,300 | $62,322 |
All Filings in GILD
Export CSV
6 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $27,415 | 217 | Shares | Sole | 2026-08-12 | |
| 2026-03-31 | $26,619 | 191 | Shares | Sole | 2026-05-13 | |
| 2025-12-31 | $33,385 | 272 | Shares | Sole | 2026-02-13 | |
| 2025-09-30 | $17,871 | 161 | Shares | Defined | 2025-11-14 | |
| 2025-06-30 | $47,451 | 428 | Shares | Defined | 2025-08-06 | |
| 2025-03-31 | $43,027 | 384 | Shares | Sole | 2025-05-15 | |
| No filing history on record for this holder in this stock. | ||||||